In meeting bio-enterprise needs, university education often revolves around introducing students in the sciences to business, managerial and other professional expertise. This paper introduces the Bio-Enterprise Innovation Expertise Model, an alternative driver for bio-enterprise-relevant education that includes science-focused students, but also draws students from non-scientific fields, which are essential to the success of any bio-enterprise. Students are grounded in the global biotechnology industry and the dynamic of expertise required throughout the innovation process â€“ from science to product. Against a backdrop of current approaches, the experience of the Business of Biotechnology (BoB) Program at the University of San Francisco (USF) is described. It utilizes the model to cohesively integrate multiple degree programs (business, law, information systems and biotechnology.) With a complement of three lecture courses and four study tours to differing global bioclusters, 95 graduate students from four degree programs undertook 170 BoB courses over five semesters. In terms of extensibility, previously unpublished Council of Graduate Schools research data is presented that shows master's focused institutions out-performing doctoral institutions at the master's level, establishing relevance of the model to all universities. The experience further demonstrates how such programs can evolve incrementally with strategic use of the model, opening numerous options for implementation, and increasing the potential to better serve bio-enterprise.Â
Pisano, G. (2006) Science Business: The Promise, the Reality, and the Future of Biotechnology. Harvard Business School Press.
Schoemaker, H. and Schoemaker, A. (1998) The three pillars of bioentrepreneurship. Nature Biotechnology: 16(Supplement 1): 13-15.
Burrill & Company. (2013) Biotech 2012: Innovating in the New Austerity, Burrill & Company 26th Annual Report on the Life Science Industry.
Ernst & Young Biotechnology Industry Report 2012. (2013) Beyond Borders: Matters of Evidence. EYGM Limited: EYG no. FN0016, 1302-1027727 LA.
James, C. (2013) Global Status of Commercialized Biotech/GM Crops: 2012. International Service for the Acquisition of Global Agri-Biotech Acquisitions ISAAA Brief 44-2012.
AGProfessional. (2012) Global enzyme market at $3.5 billion, 6% growth expected. November 27, 2012, http://www.agprofessional.com/news/Global-enzyme-market-at-35-billion-6-growth-expected-180892141.html.
Burrill, S. (2013) Improving IPO market is still not an exit path. Journal of Commercial Biotechnology 19(1): 53-54.
Coalition of State Bioscience Institutes (CSBI) and Booz & Company. (2013) Demand for Talent: Current and Projected Workforce Trends in the Life Science Industry. www.biotechinstitute.org.
Kjelstrom, J., McDonald, K., Hargadon, A., Agatstein, W. and Arnold, M. (2012) The University of California, Davis, collaborative model for biotechnology education and training. Journal of Commercial Biotechnology 18(4): 87-97.
Kunert, K., Okole, B., Vortser, B., Brewin, N. and Cullis, C. (2012) A general model for training the next generation of biotechnology entrepreneurs based on recent experience of USA-UK-South Africa collaborations. Journal of Commercial Biotechnology 18(4): 63-66.
Parthasarathy, M., Forlani, D. and Meyers, A. (2012) The University of Colorado Program in Bioinnovation and Entrepreneurship: An interdisciplinary, cross-campus model. Journal of Commercial Biotechnology 18(1): 70-78.
Langer, L. (2009) The Implementation of a proseminar course to lead change in the MS.MBA biotechnology programme at Johns Hopkins University. Journal of Commercial Biotechnology 15(2): 113-124.
Allan, L., Kistler, J., Lowe, C., Dunn, W., McGown, C. and Whitcher, G. (2009) Bioscience enterprise: Postgraduate education at Cambridge and Auckland. Journal of Commercial Biotechnology 15(3): 257-271.
Iyer, R. and Fitzgibbon, W. (2009) Building the future biotechnology workforce: A University of Houston model. Journal of Commercial Biotechnology 15(2): 171-182.
Tirrell, J. and Dewey, T. (2009) Team-based learning in Keck Graduate Instituteâ€™s professional Master of Bioscience programme. Journal of Commercial Biotechnology 15(2): 151-160.
Friedman, Y. (ed.) (2008) Best Practices in Biotechnology Education. Washington, DC: Logos Press.
Meyers, A. and Hurley, P. (2008) Bioentrepreneurship education programmes in the United States. Journal of Commercial Biotechnology 14(1): 2-12.
McCook, A. (2011) Rethinking PHDS. Nature 472: 280-282.
Colwell, R. (2009) Professional Science Master's Programs Merit Wider Support. Science 323: 1676-1677.
Theodosiou, M. and Amir-Aslani, A. (2013) The polyvalent scientist: The added value of management training. Journal of Commercial Biotechnology 19(3): 6-9.
National Research Council (2008) Science Professionals: Master's Education for a Competitive World. Washington, DC: National Academies Press.
NAS/NAE/IOM. (1995) Reshaping the Graduate Education of Scientists and Engineers. Washington, DC: National Academy Press.
Alfred P. Sloan Foundation (2013) Recently Completed Programs: Professional Science Masterâ€™s Degree, http://www.sloan.org/major-program-areas/recently-completed-programs/professional-science-masters-degree/, accessed 10 August, 2013.
National Professional Science Masterâ€™s Association (2013) PSM Program Statistics and Guidelines for Affiliation, http://www.sciencemasters.com, accessed 10 August, 2013.
Gonzales, L., Allum, J. and Remington, J. (2013) Enrollment and Degrees in Professional Science Masterâ€™s (PSM) Programs: 2012. Washington, DC: Council of Graduate Schools.
Council of Graduate Schools (2012) Keck Graduate Institute selected to administer PSM Affiliation Process, 25 January, http://www.cgsnet.org/keck-graduate-institute-selected-administer-psm-affiliation-process, accessed 10 August, 2013.
Gonzales, L. (2013) Unpublished breakdown of data from the 2012 Professional Science Master's Enrollment and Degrees Dataset, provided via email to author, March 22, 2013. Source: Washington, DC: Council of Graduate Schools.
Carnegie Foundation for the Advancement of Teaching. (2010) The Carnegie Classification of Institutions of Higher Education, http://classifications.carnegiefoundation.org/, accessed 10 August, 2013.
Bio-Link. (2013) National Advanced Technology Education (ATE) Center of Excellence for Biotechnology and Life Sciences, http://www.bio-link.org/home/, accessed 10 August, 2013.
Binder, G. (2008) Science Lessons: What the Business of Biotechnology Taught Me about Management. Harvard Business School Press.
Burns, L. (Ed.) (2012) The Business of Healthcare Innovation. Cambridge University Press.
Friedman, Y. (Ed.) (2008) Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science. Washington, DC: Logos Press.
Hine, D and Kapeleris, K. (2006) Innovation and Entrepreneurship in Biotechnology, An International Perspective: Concepts, Theories and Cases. Cheltenham UK: Edward Elgar Publishing.
Meyers, A. and Price, C. (2012) The Life Science Innovation Roadmap: Bioscience Innovation Assessment, Planning, Strategy, Execution, and Implementation. Washington, DC: Logos Press.
Salgaller, M. (2010) Biotechnology Entrepreneurship From Science to Solutions -- Start-up, Company Formation and Organization, Team, Intellectual Property, Financing, ... Regulatory Affairs, Reimbursement, Exit. Washington, DC: Logos Press.
Shimasaki, C. (2009) The Business of Bioscience: What Goes into Making a Biotechnology Product. New York: Springer.
Wasserman, N. (2012) The Founder's Dilemma: Anticipating and Avoiding the Pitfalls That Can Sink a Startup. Princeton University Press.
Gunn, M. (2007) Welcome to BioTech Nation: My Unexpected Odyssey into the Land of Small Molecules, Lean Genes, and Big Ideas. New York: AMACOM.
York, A., McCarthy, K. and Darnold, T. (2009) Teaming in biotechnology commercialization: The diversity-performance connection and how university programmes can make a difference. Journal of Commercial Biotechnology 15(1): 3-11.
York, A., McCarthy, K. and Darnold, T. (2009) Building biotechnology teams: Personality does matter. Journal of Commercial Biotechnology 15(4): 335-346.
Brown, J. and Kant, A. (2009) Creating bioentrepreneurs: How graduate student organizations foster science entrepreneurship. Journal of Commercial Biotechnology 15(2): 125-135.
Gunn, M. and Lorton, P. (2013) Measuring Program Effectiveness in Bio-Enterprise Graduate Education. Manuscript submitted for publication. Journal of Commercial Biotechnology.
Cookson, C. (2011) Regulation and Bioscience. Financial Times. FT Science with Clive Cookson, ft.com/podcasts, http://podcast.ft.com/index.php?pid=1023, accessed August 10, 2013.
Middleton, D. (2011) B-Schools Give Firms Say Amid Tough Jobs Market. The Wall Street Journal, 11 January, http://online.wsj.com/article/SB10001424052748703808704576062190021341706.html, accessed August 10, 2013.
Gunn, M. (2012) Strategic Engagement of the Science-Business Media. Journal of Commercial Biotechnology 18(2): 43-54.
Benedict XVI, P. (2008) Instruction Dignitae Personae on Certain Bioethical Questions. Congregation for the Doctrine of Faith, 20 January, http://www.vatican.va/roman_curia/congregations/cfaith/documents/rc_con_cfaith_doc_20081208_dignitas-personae_en.html, accessed August 10, 2013.
Potrykus, I. and Ammann, K. (eds.) (2010) Transgenic Plants for Food Safety: Proceedings of a Study Week of the Pontifical Academy of Sciences. New Biotechnology: Official Journal of European Federation of Biotechnology, 27(5), http://www.casinapioiv.va/content/dam/accademia/pdf/newbiotechnology.pdf, accessed August 10, 2013.
Pontifical Academy of Sciences (2004) Study Document on the Use of 'Genetically Modified Food Plants' to Combat Hunger in the World. http://www.casinapioiv.va/content/dam/accademia/pdf/es23.pdf, accessed August 10, 2013.
Back, S. (2009) The Bioentrepreneurship MBA: Options for mid-tier business schools. Journal of Commercial Biotechnology 15(2): 183-193.
Unless specified by prior arrangement, the author agrees to the following terms and assurances:
- For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
- I/we further give to the following assurances
- I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
- I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
- To the best of my/our knowledge, all the facts in the contribution are true and accurate;
- The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
- Nothing in the contribution is obscene or libellous;
- Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
- I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).